ACER | | Acer Therapeutics Inc. | ASELAGE STEVE | Director | Nov 29, 2022 | Buy | $1.22 | 409,836 | 500,000 | 483,741 | Dec 01, 2022, 04:01 PM |
BCRX | | BIOCRYST PHARMACEUTICALS INC | ASELAGE STEVE | Director | May 31, 2022 | Option Exercise | $9.31 | 569 | 5,297 | 33,728 | Jun 02, 2022, 04:43 PM |
TVTX | | Travere Therapeutics, Inc. | ASELAGE STEVE | Director | May 11, 2022 | Sale | $21.92 | 2,575 | 56,457 | 146,919 | May 12, 2022, 08:35 PM |
ACER | | Acer Therapeutics Inc. | ASELAGE STEVE | Director | Dec 09, 2021 | Buy | $2.15 | 2,016 | 4,334 | 65,921 | Dec 13, 2021, 04:02 PM |
ACER | | Acer Therapeutics Inc. | ASELAGE STEVE | Director | Dec 10, 2021 | Buy | $2.04 | 7,984 | 16,287 | 73,905 | Dec 13, 2021, 04:02 PM |
BCRX | | BIOCRYST PHARMACEUTICALS INC | ASELAGE STEVE | Director | Nov 30, 2021 | Option Exercise | $12.06 | 414 | 4,993 | 32,858 | Dec 02, 2021, 04:15 PM |
TVTX | | Travere Therapeutics, Inc. | ASELAGE STEVE | Director | Nov 16, 2021 | Sale | $29.39 | 31,800 | 934,602 | 149,494 | Nov 18, 2021, 04:08 PM |
TVTX | | Travere Therapeutics, Inc. | ASELAGE STEVE | Director | Nov 05, 2021 | Sale | $21.23 | 20,000 | 424,600 | 171,794 | Nov 09, 2021, 04:05 PM |
TVTX | | Travere Therapeutics, Inc. | ASELAGE STEVE | Director | Nov 01, 2021 | Sale | $29.48 | 5,000 | 147,400 | 23,000 | Nov 03, 2021, 04:05 PM |
TVTX | | Travere Therapeutics, Inc. | ASELAGE STEVE | Director | Nov 02, 2021 | Sale | $30.00 | 3,500 | 105,000 | 19,500 | Nov 03, 2021, 04:05 PM |
TVTX | | Travere Therapeutics, Inc. | ASELAGE STEVE | Director | Oct 07, 2021 | Option Exercise | $21.24 | 120,000 | 2,548,560 | 249,794 | Oct 08, 2021, 04:18 PM |
BCRX | | BIOCRYST PHARMACEUTICALS INC | ASELAGE STEVE | Director | Aug 31, 2021 | Option Exercise | $15.92 | 314 | 4,999 | 32,444 | Sep 02, 2021, 04:28 PM |
BCRX | | BIOCRYST PHARMACEUTICALS INC | ASELAGE STEVE | Director | May 28, 2021 | Option Exercise | $15.77 | 634 | 9,998 | 32,130 | Jun 01, 2021, 04:16 PM |
TVTX | | Travere Therapeutics, Inc. | ASELAGE STEVE | Director | Apr 16, 2021 | Option Exercise | $21.23 | 20,000 | 424,600 | 198,940 | Apr 20, 2021, 04:05 PM |
TVTX | | Travere Therapeutics, Inc. | ASELAGE STEVE | Director | Mar 17, 2021 | Option Exercise | $23.40 | 27,727 | 648,756 | 206,667 | Mar 19, 2021, 04:05 PM |
BCRX | | BIOCRYST PHARMACEUTICALS INC | ASELAGE STEVE | Director | Feb 26, 2021 | Option Exercise | $10.78 | 927 | 9,993 | 31,496 | Mar 02, 2021, 04:47 PM |
TVTX | | Travere Therapeutics, Inc. | ASELAGE STEVE | Director | Feb 02, 2021 | Option Exercise | $20.42 | 50,000 | 1,021,000 | 221,667 | Feb 02, 2021, 09:18 PM |
TVTX | | Travere Therapeutics, Inc. | ASELAGE STEVE | Director | Dec 15, 2020 | Sale | $26.02 | 5,549 | 144,385 | 196,667 | Dec 16, 2020, 08:55 PM |
TVTX | | Travere Therapeutics, Inc. | ASELAGE STEVE | Director | Dec 02, 2020 | Sale | $23.43 | 7,891 | 184,849 | 202,216 | Dec 04, 2020, 07:00 PM |
BCRX | | BIOCRYST PHARMACEUTICALS INC | ASELAGE STEVE | Director | Nov 30, 2020 | Option Exercise | $5.11 | 1,956 | 9,995 | 30,569 | Dec 02, 2020, 04:19 PM |
RTRX | | Retrophin, Inc. | ASELAGE STEVE | Director | Nov 05, 2020 | Sale | $21.26 | 2,500 | 53,150 | 233,732 | Nov 06, 2020, 08:56 PM |
RTRX | | Retrophin, Inc. | ASELAGE STEVE | Director | Nov 06, 2020 | Sale | $23.00 | 20,625 | 474,375 | 213,107 | Nov 06, 2020, 08:56 PM |
BCRX | | BIOCRYST PHARMACEUTICALS INC | ASELAGE STEVE | Director | Aug 31, 2020 | Option Exercise | $4.15 | 2,409 | 9,997 | 28,613 | Sep 02, 2020, 04:36 PM |
RTRX | | Retrophin, Inc. | ASELAGE STEVE | Director | Aug 05, 2020 | Sale | $19.68 | 2,500 | 49,200 | 236,232 | Aug 06, 2020, 04:07 PM |
ACER | | Acer Therapeutics Inc. | ASELAGE STEVE | Director | Jul 24, 2020 | Buy | $3.50 | 45,000 | 157,500 | 63,905 | Jul 28, 2020, 09:02 AM |
RTRX | | Retrophin, Inc. | ASELAGE STEVE | Director | Jun 25, 2020 | Sale | $20.00 | 10,000 | 200,000 | 238,732 | Jun 29, 2020, 09:02 PM |
BCRX | | BIOCRYST PHARMACEUTICALS INC | ASELAGE STEVE | Director | Jun 01, 2020 | Option Exercise | $4.49 | 1,112 | 4,998 | 26,204 | Jun 03, 2020, 04:24 PM |
RTRX | | Retrophin, Inc. | ASELAGE STEVE | Director | May 12, 2020 | Sale | $17.16 | 1,000 | 17,160 | 252,857 | May 14, 2020, 08:59 PM |
RTRX | | Retrophin, Inc. | ASELAGE STEVE | Director | May 13, 2020 | Sale | $16.41 | 4,063 | 66,674 | 248,794 | May 14, 2020, 08:59 PM |
RTRX | | Retrophin, Inc. | ASELAGE STEVE | Director | May 14, 2020 | Sale | $15.09 | 3,062 | 46,206 | 245,732 | May 14, 2020, 08:59 PM |
RTRX | | Retrophin, Inc. | ASELAGE STEVE | Director | May 05, 2020 | Sale | $15.88 | 2,500 | 39,700 | 253,857 | May 06, 2020, 04:09 PM |
RTRX | | Retrophin, Inc. | ASELAGE STEVE | Director | Mar 05, 2020 | Sale | $15.36 | 4,359 | 66,939 | 256,357 | Mar 09, 2020, 09:03 PM |
BCRX | | BIOCRYST PHARMACEUTICALS INC | ASELAGE STEVE | Director | Mar 01, 2020 | Option Exercise | $3.00 | 1,666 | 4,998 | 25,092 | Mar 03, 2020, 12:00 AM |
RTRX | | Retrophin, Inc. | ASELAGE STEVE | Director | Feb 05, 2020 | Sale | $16.62 | 2,500 | 41,550 | 248,466 | Feb 07, 2020, 07:38 PM |
BCRX | | BIOCRYST PHARMACEUTICALS INC | ASELAGE STEVE | Director | Dec 01, 2019 | Option Exercise | $2.85 | 1,754 | 4,999 | 23,426 | Dec 03, 2019, 05:14 PM |
RTRX | | Retrophin, Inc. | ASELAGE STEVE | Director | Nov 29, 2019 | Sale | $13.91 | 5,000 | 69,552 | 250,966 | Nov 29, 2019, 09:27 PM |
BCRX | | BIOCRYST PHARMACEUTICALS INC | ASELAGE STEVE | Director | Nov 18, 2019 | Buy | $1.45 | 15,000 | 21,750 | 21,672 | Nov 18, 2019, 04:01 PM |
BCRX | | BIOCRYST PHARMACEUTICALS INC | ASELAGE STEVE | Director | Sep 01, 2019 | Option Exercise | $2.99 | 1,672 | 4,999 | 6,672 | Sep 04, 2019, 04:14 PM |
ACER | | Acer Therapeutics Inc. | ASELAGE STEVE | Director | Jul 03, 2019 | Buy | $3.72 | 5,000 | 18,581 | 18,905 | Jul 05, 2019, 04:08 PM |
BCRX | | BIOCRYST PHARMACEUTICALS INC | ASELAGE STEVE | Director | May 22, 2019 | Buy | $3.57 | 3,000 | 10,710 | 5,000 | May 24, 2019, 04:20 PM |
RTRX | | Retrophin, Inc. | ASELAGE STEVE | Director | May 14, 2019 | Sale | $17.79 | 1,838 | 32,698 | 257,804 | May 16, 2019, 09:34 PM |
RTRX | | Retrophin, Inc. | ASELAGE STEVE | Director | May 15, 2019 | Sale | $17.82 | 1,838 | 32,753 | 255,966 | May 16, 2019, 09:34 PM |
BCRX | | BIOCRYST PHARMACEUTICALS INC | ASELAGE STEVE | Director | Mar 12, 2019 | Buy | $8.30 | 2,000 | 16,600 | 2,000 | Mar 14, 2019, 04:18 PM |
RTRX | | Retrophin, Inc. | ASELAGE STEVE | Chief Executive Officer | Feb 11, 2019 | Sale | $21.38 | 1,065 | 22,770 | 258,707 | Feb 13, 2019, 08:47 PM |
RTRX | | Retrophin, Inc. | ASELAGE STEVE | Chief Executive Officer | Feb 12, 2019 | Sale | $21.50 | 1,065 | 22,898 | 257,642 | Feb 13, 2019, 08:47 PM |
RTRX | | Retrophin, Inc. | ASELAGE STEVE | Chief Executive Officer | Dec 20, 2018 | Sale | $21.97 | 6,188 | 135,958 | 265,960 | Dec 21, 2018, 08:20 PM |
RTRX | | Retrophin, Inc. | ASELAGE STEVE | Chief Executive Officer | Dec 21, 2018 | Sale | $21.79 | 6,188 | 134,829 | 260,672 | Dec 21, 2018, 08:20 PM |
RTRX | | Retrophin, Inc. | ASELAGE STEVE | Chief Executive Officer | Dec 07, 2018 | Sale | $24.04 | 10 | 240 | 251,523 | Dec 07, 2018, 09:15 PM |
RTRX | | Retrophin, Inc. | ASELAGE STEVE | Chief Executive Officer | Nov 14, 2018 | Sale | $23.74 | 5,550 | 131,735 | 259,433 | Nov 16, 2018, 07:16 PM |
RTRX | | Retrophin, Inc. | ASELAGE STEVE | Chief Executive Officer | Nov 15, 2018 | Sale | $24.32 | 5,550 | 134,969 | 254,369 | Nov 16, 2018, 07:16 PM |
RTRX | | Retrophin, Inc. | ASELAGE STEVE | Chief Executive Officer | Aug 31, 2018 | Option Exercise | $20.35 | 24,000 | 488,400 | 257,883 | Aug 31, 2018, 07:54 PM |
RTRX | | Retrophin, Inc. | ASELAGE STEVE | Chief Executive Officer | Mar 07, 2018 | Option Exercise | $6.00 | 278 | 1,668 | 221,383 | Mar 08, 2018, 09:13 PM |
ACER | | Acer Therapeutics Inc. | ASELAGE STEVE | Director | Dec 14, 2017 | Buy | $12.00 | 2,000 | 24,000 | 13,905 | Dec 18, 2017, 04:01 PM |
RTRX | | Retrophin, Inc. | ASELAGE STEVE | Chief Executive Officer | Jun 14, 2017 | Buy | $17.85 | 5,000 | 89,250 | 245,556 | Jun 14, 2017, 02:40 PM |
RTRX | | Retrophin, Inc. | ASELAGE STEVE | Chief Executive Officer | Nov 22, 2016 | Sale | $21.30 | 3,200 | 68,160 | 240,556 | Nov 23, 2016, 04:25 PM |
RTRX | | Retrophin, Inc. | ASELAGE STEVE | Chief Executive Officer | Nov 21, 2016 | Sale | $21.00 | 5,000 | 105,000 | 243,756 | Nov 23, 2016, 04:25 PM |
RTRX | | Retrophin, Inc. | ASELAGE STEVE | Chief Executive Officer | Nov 09, 2015 | Sale | $18.77 | 30,000 | 563,100 | 338,756 | Nov 12, 2015, 01:03 PM |
RTRX | | Retrophin, Inc. | ASELAGE STEVE | Chief Executive Officer | Nov 10, 2015 | Sale | $18.72 | 30,000 | 561,600 | 308,756 | Nov 12, 2015, 01:03 PM |
RTRX | | Retrophin, Inc. | ASELAGE STEVE | Chief Executive Officer | Nov 20, 2014 | Buy | $8.20 | 1,300 | 10,660 | 363,056 | Nov 21, 2014, 06:02 PM |
RTRX | | Retrophin, Inc. | ASELAGE STEVE | Chief Executive Officer | Nov 21, 2014 | Buy | $8.50 | 8,700 | 73,950 | 371,756 | Nov 21, 2014, 06:02 PM |
RTRX | | Retrophin, Inc. | ASELAGE STEVE | Director | Aug 15, 2013 | Buy | $4.50 | 556 | 2,502 | 261,756 | Dec 27, 2013, 07:59 PM |
BMRN | | BIOMARIN PHARMACEUTICAL INC | ASELAGE STEVE | EVP, Chief Business Officer | Jul 02, 2012 | Option Exercise | $28.77 | 190,690 | 5,486,151 | 154,375 | Jul 05, 2012, 06:30 PM |
BMRN | | BIOMARIN PHARMACEUTICAL INC | ASELAGE STEVE | EVP, Chief Business Officer | May 15, 2012 | Sale | $27.98 | 20,000 | 559,673 | 69,030 | May 17, 2012, 06:10 PM |
BMRN | | BIOMARIN PHARMACEUTICAL INC | ASELAGE STEVE | EVP, Chief Business Officer | May 11, 2012 | Sale | $27.55 | 47,690 | 1,313,828 | 80,560 | May 15, 2012, 08:02 PM |
BMRN | | BIOMARIN PHARMACEUTICAL INC | ASELAGE STEVE | EVP, Chief Business Officer | Apr 30, 2012 | Option Exercise | $19.35 | 1,006 | 19,462 | 47,685 | May 10, 2012, 05:46 PM |
BMRN | | BIOMARIN PHARMACEUTICAL INC | ASELAGE STEVE | EVP, Chief Business Officer | Oct 28, 2011 | Option Exercise | $24.70 | 33,750 | 833,456 | 63,353 | Oct 31, 2011, 07:17 PM |
BMRN | | BIOMARIN PHARMACEUTICAL INC | ASELAGE STEVE | EVP, Chief Business Officer | May 25, 2011 | Option Exercise | $22.16 | 18,354 | 406,816 | 53,155 | May 26, 2011, 06:55 PM |
BMRN | | BIOMARIN PHARMACEUTICAL INC | ASELAGE STEVE | EVP, Chief Business Officer | May 26, 2011 | Sale | $22.17 | 81,024 | 1,795,901 | 84,490 | May 26, 2011, 06:55 PM |
BMRN | | BIOMARIN PHARMACEUTICAL INC | ASELAGE STEVE | EVP, Chief Business Officer | Apr 29, 2011 | Option Exercise | $11.64 | 1,597 | 18,583 | 31,478 | May 05, 2011, 01:31 PM |
BMRN | | BIOMARIN PHARMACEUTICAL INC | ASELAGE STEVE | EVP, Chief Business Officer | May 03, 2011 | Sale | $22.24 | 20,622 | 458,585 | 41,789 | May 05, 2011, 01:31 PM |
BMRN | | BIOMARIN PHARMACEUTICAL INC | ASELAGE STEVE | EVP, Chief Business Officer | Oct 29, 2010 | Option Exercise | $11.64 | 294 | 3,421 | 37,881 | Nov 19, 2010, 03:50 PM |
BMRN | | BIOMARIN PHARMACEUTICAL INC | ASELAGE STEVE | EVP, Chief Business Officer | Nov 17, 2010 | Sale | $25.12 | 9,000 | 226,095 | 61,256 | Nov 19, 2010, 03:50 PM |
BMRN | | BIOMARIN PHARMACEUTICAL INC | ASELAGE STEVE | EVP, Chief Business Officer | Nov 18, 2010 | Sale | $20.13 | 62,750 | 1,263,032 | 61,756 | Nov 19, 2010, 03:50 PM |
BMRN | | BIOMARIN PHARMACEUTICAL INC | ASELAGE STEVE | EVP, Chief Business Officer | Sep 08, 2010 | Option Exercise | $16.87 | 70,000 | 1,180,900 | 72,587 | Sep 09, 2010, 07:18 PM |